Showing 2381-2390 of 4165 results for "".
- Dr. David Shafer Explains Benefits of Breast Augmentation Visualization Toolhttps://modernaesthetics.com/news/dr-david-shafer-explains-benefits-of-breast-augmentation-visualization-tool/2475364/The Natrelle Breast Visualizer, powered by Crisalix, allows patients to preview their potential breast augmentation results in just a few clicks. Modern Aesthetics spoke with double board-certified plastic surgeon David Shafer, MD, FACS, about the challenges this technology help
- skinbetter science® Launches Even Intensive Skin Tone Correcting Serumhttps://modernaesthetics.com/news/skinbetter-science-launches-even-intensive-skin-tone-correcting-serum/2475366/skinbetter science® has announced the launch Even Intensive Skin Tone Correcting Serum, an advanced discoloration treatment formulated to address persistent dark marks, uneven tone, and skin texture irregularities. According to
- Johnson & Johnson MedTech Launches Larger-Sized Breast Implants for Post-Mastectomy Reconstructionhttps://modernaesthetics.com/news/johnson-johnson-medtech-launches-larger-sized-breast-implants-for-post-mastectomy-reconstruction/2475365/Johnson & Johnson MedTech has announced the U.S. launch of MENTORTM Memory GelTM Enhanced Breast Implants, a new line of breast implants specifically developed for women undergoing primary or revision reconstruction after mastectomy. The implants, which received FDA appr
- Skin Clique Expands Virtual Services with Nationwide Esthetician Programhttps://modernaesthetics.com/news/skin-clique-expands-virtual-services-with-nationwide-esthetician-program/2475363/Skin Clique, a physician-founded aesthetic care provider, has launched a virtual Esthetician Program to expand access to individualized skincare consultations across the United States. The program integrates licensed estheticians into the company’s existin
- Teoxane Launches Consumer Access to Dermocosmetic Skincare Line in U.S.https://modernaesthetics.com/news/teoxane-launches-consumer-access-to-dermocosmetic-skincare-line-in-us/2475362/Teoxane has announced the U.S. launch of its dermocosmetics line, making its clinically developed skincare products available directly to consumers for the first time through its new online platform, teoxane.us. Previously offered exclusively through aesthetic professionals, the Swiss comp
- BOTOX® Cosmetic Expands Support Program for Women Entrepreneurs with 2025 Confidence Projecthttps://modernaesthetics.com/news/botox-cosmetic-expands-support-program-for-women-with-2025-confidence-project/2475360/Allergan Aesthetics, an AbbVie company, has announced the return and expansion of its initiative aimed at addressing the “Confidence Gap” among women entrepreneurs. The 2025 edition of The Confidence Project: Empowering Women Entrepreneurs will support 250 founders through mentorship and business
- Men’s Aesthetic Practice Announces New Chief Medical Director for San Diego Clinichttps://modernaesthetics.com/news/mens-aesthetic-practice-announces-new-chief-medical-director-for-san-diego-clinic/2475355/Lushful Aesthetics, a leader in specialized sexual health and enhancement procedures, named Dr. Carlton Thomas as chief medical director of its new clinic in San Diego. Dr. Thomas will oversee medical operations next to Lushful Aesthetics founder Chris Bustamante, DNP, NP-C. Dr. Thomas gai
- iS Clinical Executives Explain Impact of New Peel Systemhttps://modernaesthetics.com/news/is-clinical-executives-explain-impact-of-new-peel-system/2475354/The next evolution of iS Clinical’s Active Peel System is the iS Clinical Extra Strength Active Peel Brightening System, which launched this week exclusively through authorized iS Clinical professionals nationwide, the company announced. The system’s professional-grade results include three times
- Allergan Aesthetics Submits BLA for TrenibotulinumtoxinE for Glabellar Lineshttps://modernaesthetics.com/news/abbvie-submits-bla-for-trenibotulinumtoxine-for-glabellar-lines/2475351/Allergan Aesthetics, an AbbVie Company, has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for trenibotulinumtoxinE (TrenibotE), seeking approval for the treatment of moderate to severe glabellar lines. TrenibotE, a serotype E botulinum toxin
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://modernaesthetics.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2475350/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick skin types